Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16463400 | 0.86 | ALDH1A1 (0.36) | ALDH1A1ACHEPAOXGAALMNA | |
| SCHEMBL15571081 | 0.84 | TSHR (0.42) | ALDH1A1TSHRTDP1LMNA | |
| SCHEMBL11550538 | 0.81 | CYP1A1 (0.32) | ALDH1A1TDP1LMNA | |
| SCHEMBL11550537 | 0.81 | CYP1A1 (0.32) | ALDH1A1TDP1LMNA | |
| SCHEMBL11232780 | 0.77 | ALDH1A1 (0.39) | ALDH1A1ACHEPAOXGAATSHR | |
| SCHEMBL11551788 | 0.77 | ALDH1A1 (0.30) | ALDH1A1TDP1LMNA | |
| SCHEMBL11551792 | 0.77 | ALDH1A1 (0.30) | ALDH1A1TDP1LMNA | |
| SCHEMBL22186415 | 0.75 | LMNA (0.32) | ALDH1A1TSHRLMNA | |
| SCHEMBL11806205 | 0.75 | ALDH1A1 (0.45) | ALDH1A1TSHRTDP1LMNA | |
| SCHEMBL11546263 | 0.74 | PTPN1 (0.41) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104704094-B | Flavor and fragrance formulation (III) | 帝斯曼知识产权资产管理有限公司 | 2020-06-23 | — | — | CN | disclosed |
| EP-2904076-B1 | FLAVOR AND FRAGRANCE FORMULATION (III) | DSM IP ASSETS BV (NL) | 2018-12-12 | — | — | EP | disclosed |
| US-9567286-B2 | Flavor and fragrance formulation (III) | DSM IP ASSETS B.V. (NL) | 2017-02-14 | — | — | US | disclosed |
| US-20150307439-A1 | FLAVOR AND FRAGRANCE FORMULATION (I) | DSM IP ASSETS B.V. (NL) | 2015-10-29 | — | — | US | disclosed |
| US-20150307439-A1 | FLAVOR AND FRAGRANCE FORMULATION (I) | DSM IP ASSETS B.V. (NL) | 2015-10-29 | — | — | US | disclosed |
| US-20150246868-A1 | FLAVOR AND FRAGRANCE FORMULATION (III) | DSM IP ASSETS B.V. (NL) | 2015-09-03 | — | — | US | disclosed |
| EP-2904076-A1 | FLAVOR AND FRAGRANCE FORMULATION (III) | DSM IP Assets B.V. (NL) | 2015-08-12 | — | — | EP | disclosed |
| EP-2904080-A2 | FLAVOR AND FRAGRANCE FORMULATION (I) | DSM IP Assets B.V. (NL) | 2015-08-12 | — | — | EP | disclosed |
| WO-2014056847-A1 | FLAVOR AND FRAGRANCE FORMULATION (II) | DSM IP ASSETS B.V. (NL) | 2014-04-17 | — | — | WO | disclosed |
| WO-2014056848-A1 | FLAVOR AND FRAGRANCE FORMULATION (III) | DSM IP ASSETS B.V. (NL) | 2014-04-17 | — | — | WO | disclosed |
| WO-2014056851-A2 | FLAVOR AND FRAGRANCE FORMULATION (I) | DSM IP ASSETS B.V. (NL) | 2014-04-17 | — | — | WO | disclosed |
| US-7790668-B2 | 2-methoxy-2,6-dimethyloctanal and its use as a fragrance ingredient | GIVAUDAN SA (CH) | 2010-09-07 | — | — | US | disclosed |
| EP-1924544-B1 | 6-METHOXY-2,6-DIMETHYLOCTANAL AND ITS USE AS A FRAGRANCE INGREDIENT | GIVAUDAN SA (CH) | 2009-01-14 | — | — | EP | disclosed |
| US-20080261860-A1 | 2-Methoxy-2, 6-Dimethyloctanal and Its Use as a Fragrance Ingredient | GIVAUDAN SA (CH) | 2008-10-23 | — | — | US | disclosed |
| EP-1924544-A1 | 6-METHOXY-2,6-DIMETHYLOCTANAL AND ITS USE AS A FRAGRANCE INGREDIENT | Givaudan SA (CH) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007030967-A1 | 6-METHOXY-2,6-DIMETHYLOCTANAL AND ITS USE AS A FRAGRANCE INGREDIENT | GIVAUDAN SA (CH) | 2007-03-22 | — | — | WO | disclosed |
| EP-1764355-A1 | 6-methoxy-2,6-dimethyloctanal and its use as a fragrance ingredient | Givaudan S.A. (CH) | 2007-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246868-A1 | FLAVOR AND FRAGRANCE FORMULATION (III) | NISCH, TAS2R5, OR10J3 | ALDH1A1 175/4885ACHE 479/4885PAOX 861/4885 |
| US-20150307439-A1 | FLAVOR AND FRAGRANCE FORMULATION (I) | NISCH, TAS2R5, FDFT1 | ALDH1A1 97/4885ACHE 442/4885PAOX 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.